Abstract
Conference Poster Presentation: EHA & BSH (2024)
•Significance: Presented a poster on the proteomic profiling of QUB-2392’s effects on leukaemia cell lines, emphasizing its role in oncogene suppression and tumour suppressor gene activation.
•Contribution: Authored the poster and responded to queries from ECRs and senior researchers, highlighting the novel approach of targeting leukaemia with bioactive peptides.
•Impact: Featured in an interview published by the British Society for Haematology. This amplified the visibility of my research among clinical and academic audiences.
•Significance: Presented a poster on the proteomic profiling of QUB-2392’s effects on leukaemia cell lines, emphasizing its role in oncogene suppression and tumour suppressor gene activation.
•Contribution: Authored the poster and responded to queries from ECRs and senior researchers, highlighting the novel approach of targeting leukaemia with bioactive peptides.
•Impact: Featured in an interview published by the British Society for Haematology. This amplified the visibility of my research among clinical and academic audiences.
| Original language | English |
|---|---|
| Publication status | Published - 26 Apr 2024 |
| Event | British Society for Haematology 64th Annual Scientific Meeting - ACC Liverpool, Liverpool, United Kingdom Duration: 28 Apr 2024 → 30 Apr 2024 Conference number: EHA24-PO07 https://confpartners.eventsair.com/QuickEventWebsitePortal/bshasm2024/bsh-programme/Portal/Closed |
Conference
| Conference | British Society for Haematology 64th Annual Scientific Meeting |
|---|---|
| Abbreviated title | BSH 2024 |
| Country/Territory | United Kingdom |
| City | Liverpool |
| Period | 28/04/24 → 30/04/24 |
| Internet address |
